Clinical trial
Cycled Phototherapy: A Safer Effective Method to Control the Serum Bilirubin Of Extremely Premature Infants?
NCT03927833 is registered in ClinicalTrials.gov with NICHD Neonatal Research Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cycled Phototherapy: A Safer Effective Method to Control the Serum Bilirubin Of Extremely Premature Infants?
- Lead sponsor
- NICHD Neonatal Research Network
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 16, 2020
- Completion date
- July 31, 2027
- Enrollment
- 1,700 (estimated)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
hyper bilirubinemia, premature infant